arrow
C

Chang Xu

department of radiation oncology
H指数:18
被引数:1,454

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combination of cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) with chemotherapy in anti-PD-1-resistant recurrent or metastatic nasopharyngeal carcinoma: An open-label, single-arm, phase II clinical trial

卡度尼利单抗(抗PD-1和CTLA-4双特异性抗体)联合化疗治疗抗PD-1耐药的复发或转移性鼻咽癌:一项开放标签、单臂、II期临床试验

2024-09-010
PRE
Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay
2023-07-314
OAAI
A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency
2021-04-1624
OAAI